Topics

Inozyme Pharma, Inc. Company Profile

03:54 EST 27th January 2020 | BioPortfolio

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcification of soft tissues and under mineralization of bone. The company was founded in 2016 with technology licensed from Yale University.


News Articles [917 Associated News Articles listed on BioPortfolio]

Inozyme Pharma Names Pedro Huertas Chief Medical Officer

Pedro Heurtas has joined Inozyme Pharma as chief medical officer, the same position he held most recently at Sentien Pharmaceuticals. His experience also includes positions at Eloxx Pharmaceuticals, G...

Inozyme Pharma Expands Medical Leadership Team

Strengthens Inozyme’s Ability to Advance Lead Candidate, INZ-701, into Clinical Trials Inozyme Pharma Inc., a biotechnology company developing novel medicines to treat rare and life-threatening mi...

LEO Pharma Signs Agreement to Divest Emollients and Proctology Portfolio to Karo Pharma

BALLERUP, Denmark–(BUSINESS WIRE)–Today, LEO Pharma announced the sale of 10 products to Karo Pharma AB for 90 MEUR. The divested portfolio is non-core to LEO Pharma’s business, and was ...

INNATE PHARMA: Innate Pharma Announces Closing of Global Offering

INNATE PHARMA S.A. (Euronext Paris: IPH - ISIN: FR0010331421; Nasdaq: IPHA) ("Innate Pharma" or the "Company"), a French biotechnology company focused on discovering, developing and commercializing...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Top 10 Pharma Companies of 2019

Overall, the top 10 pharma companies on this year’s GEN list generated a combined $1.792 trillion in market cap,is down 2.9% fromGEN’s A-List of Top 10 Pharma Companies of 2018, but up 4% from t...

Karo Pharma Divests Hydrokortison Trimb to Evolan Pharma

HUDDINGE, Sweden, Nov. 27, 2019 /PRNewswire/ -- As previously communicated, Karo Pharma Aktiebolag ("Karo Pharma") voluntarily and within a certain time undertook to divest Hydrokortison Trimb and...

New TOC Analyzers for the Pharma Industry Simplify Cleaning Validation and Total Protein Determination

The TOC (total organic carbon) analyzers of the multi N/C pharma series from Analytik Jena are being expanded. With the multi N/C 2100S pharma and 3100 pharma, two new device models are being introduc...

Drugs and Medications [53 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]

NA

Ribavirin [aurobindo pharma limited]

NA

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

III. THE ROLE OF THE RESEARCH ETHICS COMMITTEES IN THE REGULATION OF PHARMA-SPONSORED STUDIES.

Participants of Pharma-sponsored research are exposed to risks, benefits, and uncertainties that do not occur in other forms of clinical studies. Ethics committees represent the subjects' first line o...

The Art of Virtualizing Pharma R&D.

Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma.

Potential effects of increased openness in pharma: the original knowledge behind new drugs.

This study seeks to determine potential changes in the degree of openness in pharmaceutical R&D by investigating where the knowledge behind new molecular entities (NMEs) comes from in terms of type of...

Clinical Trials [97 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [844 Associated Companies listed on BioPortfolio]

Inozyme Pharma, Inc.

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcif...

Inozyme Pharma Inc.

Inozyme Pharma is a biotechnology company committed to developing novel medicines to treat rare metabolic diseases characterized by mineral imbalances that lead to over-calcified soft tissues and und...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Inozyme Pharma, Inc." on BioPortfolio

We have published hundreds of Inozyme Pharma, Inc. news stories on BioPortfolio along with dozens of Inozyme Pharma, Inc. Clinical Trials and PubMed Articles about Inozyme Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inozyme Pharma, Inc. Companies in our database. You can also find out about relevant Inozyme Pharma, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record